Literature DB >> 2458183

Cytokines produced by blood mononuclear cells stimulated with the streptococcal preparation OK-432: effect on production by supplementing the medium with xenogeneic serum.

M Fujii1, T Abo, K Kumagai.   

Abstract

Human blood MNC were stimulated for 7 days with a streptococcal preparation, OK-432, in a medium supplemented with either 10% autologous serum (autoserum) or 10% FCS. Cytokines, including IL-2, IL-1, IFN, and TNF in the supernatants, and antitumor cytotoxicity of MNC were analyzed. None of the IL-2 was detectable during the culture in medium with autoserum, although significant enhancement of cytotoxicity was observed at day 1. On the other hand, production of IL-2 and higher cytotoxicity were induced in the medium with FCS. Even a control culture of MNC unstimulated with OK-432 in the medium with FCS, showed a slight but significant amount of IL-2 and considerable cytotoxicity. However, such a culture in the medium with autoserum showed no such IL-2 production or cytotoxicity. The cytotoxicity induced in the medium with FCS was significantly inhibited by the addition of anti-IL-2 antibody to the culture as well as by the addition of anti-IFN gamma antibody, whereas the cytotoxicity in the medium with autoserum was not inhibited at all by anti-IL-2 antibody. Therefore, the cytotoxicity induced in the medium with FCS included IL-2-induced killer activity, i.e., LAK activity. Similarly, the levels of IL-1, IFN, and TNF production in the supernatants were variable depending on the serum used to supplement the medium. The nonspecific production of IL-2 and the unexpected induction of cytotoxicity were consistently provoked in the medium using several different lots of FCS, but not in the medium with human allogeneic sera or pooled AB serum nor in that with autoserum. It was revealed that the source of sera used to supplement the medium is an important factor affecting the results of analysis of cytokine production and cytotoxicity of MNC induced by certain stimulants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458183     DOI: 10.1007/bf00200011

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  20 in total

1.  Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.

Authors:  M Saito; O Ichimura; M Kataoka; Y Moriya; K Ueno; Y Sugawara; M Nanjo; N Ishida
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.

Authors:  R Suzuki; S Suzuki; M Igarashi; K Kumagai
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

3.  Selective phagocytosis of gram-positive bacteria and interleukin 1-like factor production by a subpopulation of large granular lymphocytes.

Authors:  T Abo; S Sugawara; A Amenomori; H Itoh; H Rikiishi; I Moro; K Kumagai
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

4.  Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors.

Authors:  A Uchida; E Klein
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

5.  Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.

Authors:  Y B Kim
Journal:  Prog Clin Biol Res       Date:  1985

6.  Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma.

Authors:  K Nara; H Odagiri; M Fujii; Y Yamanaka; M Yokoyama; T Morita; M Sasaki; M Kon; T Abo
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].

Authors:  N Ishida; M Saito; M Nanjo
Journal:  Gan To Kagaku Ryoho       Date:  1984-12

8.  Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.

Authors:  K Oshimi; S Kano; F Takaku; K Okumura
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

9.  Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.

Authors:  B Bonavida; J Katz; T Hoshino
Journal:  Cell Immunol       Date:  1986-10-01       Impact factor: 4.868

10.  Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction.

Authors:  R Suzuki; S Suzuki; T Takahashi; K Kumagai
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  5 in total

1.  Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432.

Authors:  S Aiba; H Tagami
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Mechanism of stimulation of T cells by Streptococcus pyogenes: isolation of a major mitogenic factor, cytoplasmic membrane-associated protein.

Authors:  T Itoh; H Satoh; N Isono; H Rikiishi; K Kumagai
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.

Authors:  J Tarkkanen; E Saksela
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

4.  Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression.

Authors:  D K Blanchard; S McMillen; S L Hoffman; J Y Djeu
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  The changing pattern of the splenic lymphocyte subsets in tumor-bearing mice after oral treatment with OK-432.

Authors:  Y Akamatsu; S Fuchimoto; K Orita
Journal:  Jpn J Cancer Res       Date:  1992-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.